key: cord-0821964-uegfr5am
authors: Anurag, Aditya; Kumar Jha, Prakash; Kumar, Abhishek
title: Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients
date: 2020-11-02
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2020.10.029
sha: 57723fadb42f9ab1f2e52d9da98c49a8c355fefd
doc_id: 821964
cord_uid: uegfr5am

BACKGROUND: SARS-CoV-2 infection alters various blood parameters, which may indicate disease severity and thus help in better clinical management. AIM: To study the association between various hematological parameters and disease severity of COVID-19. To analyze the effects of hypertension and diabetes on neutrophil-lymphocyte ratio and neutrophil-monocyte ratio in patients suffering from COVID-19. MATERIALS AND METHODS: The study was a cross-sectional study involving 148 laboratory-confirmed cases of SARS-CoV-2 infection. The patients were divided into three groups on the basis of disease severity. Various hematological parameters were analyzed. The effects of hypertension and diabetes on NLR and NMR in COVID-19 patients were evaluated. RESULTS: Of the 148 patients, 78.4%, 8.1% and 13.5% cases were in the mild, moderate and severe groups, respectively. Mean age was 42.63 ± 16.04 years (IQR: 29, 54.75; Range: 7–74). 58.8% patients were male while the rest (42.2%) were female. Mean TLC (cells/mm(3)), neutrophil (%), lymphocyte (%), monocyte (%), eosinophil (%), neutrophil-lymphocyte ratio (NLR) and neutrophil-monocyte ratio (NMR) among mild, moderate and severe COVID-19 was statistically significant (p < 0.05). Basophil (%) and lymphocyte-monocyte ratio (LMR) was statistically insignificant among the three groups. Lymphocyte (%), monocyte (%) and eosinophil (%) were negatively correlated to disease severity. Among diabetics, both NLR and NMR were statistically significant (p < 0.05). However, among hypertensive cases, only the NLR was statistically significant. CONCLUSION: Older age, higher TLC, neutrophilia, lymphopenia, eosinopenia, high NLR and high NMR are associated with severe COVID-19. High NLR and high NMR are indicative of severe disease among diabetic patients. High NLR also indicates severe disease among hypertensive patients.

Ever since the emergence of COVID-19, the disease has affected 36,754,395 individuals worldwide and has resulted in deaths of 1,064,838 patients until the time of writing this report. [1] The agent responsible for this pandemic is a coronavirus, which was named SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2) by the W.H.O on 11 February, 2020. [2] With a case fatality rate (CFR) of around 4% and no effective vaccine or treatment expected to come to the fore in near future, the problems posed by COVID-19 pandemic is unprecedented.

The knowledge regarding the spectrum of effects that SARS-CoV-2 may have on its host and the modes of its transmission among humans is still evolving. The common clinical features of COVID-19 include fever, dry cough, dyspnea, fatigue, myalgia, headache, anosmia, ageusia and diarrhea. [3] , [4] Severe cases may develop life threatening complications like acute respiratory distress syndrome (ARDS), coagulopathy etc. Also, according to WHO, current evidences J o u r n a l P r e -p r o o f suggest that SARS-CoV-2 spreads among people via direct contact routes and by droplet, airborne and, fomite transmission. [5] COVID-19 may involve many organ systems in its host. Studies suggest that hematological profiles change during the course of SARS-CoV-2 illness. Neutrophils are involved in early antiviral defense. However, during severe pneumonia, neutrophils become cytotoxic through degranulation and lysis. [6] Studies have suggested that neutrophil recruitment may exacerbate COVID-19 immunopathology. [7] A study involving 90 hospitalized COVID-19 patients reported an association between lymphopenia and disease severity. [8] Another study involving 93 laboratory-confirmed cases of COVID-19 identified neutrophil-lymphocyte ratio (NLR) as an independent marker of poor clinical outcome in COVID-19. [9] , [10] Age≥60 years, hypertension, diabetes mellitus, chronic lung/liver/kidney disease, cerebrovascular disease, obesity (BMI > 25kg/m 2 ), cancer and smoking are a few risk factors that complicate the disease course in COVID-19. [4] , [11] Dysregulated glucose metabolism in diabetes may lead to immune dysfunction and hypercoagulable state which may complicate SARS-CoV-2 infection. Hence, diabetes mellitus was found to be an independent risk factor for progression of COVID-19. [12] SARS-CoV-2 enters its target cell via angiotensin converting enzyme-2 (ACE-2) receptors. [13] Treatment of hypertension with ACE inhibitors and ARBs (angiotensin receptor blockers) is postulated to increase ACE-2 receptor expression, thus facilitating SARS-CoV-2 infection. [14] India caters the health requirements of a large population with very limited resources. Therefore Table- 2)

The statistical analysis of total leukocyte count (TLC) and differential leukocyte count (DLC) has been presented in Table- However, the basophil differential count (in %age) (mean=0.25±0.53) between the three groups was found to be statistically insignificant (p=0.166). (Table- Statistical analysis of NMR among diabetic patients was also significant (p= 0.007). (Table- 3)

The NLR was also significantly higher among hypertensive group (mean=16.14±14.91). Among non-hypertensive population, the mean NLR was 6.34±17.82 (p=0.016). However, mean NMR for hypertensive patients was not found to be statistically significant (p=0.364). (Table-4 

The mean age of patients included in this study was around 40 years. In this study, older age was associated with severe illness. Many similar studies have also found poorer outcome of COVID-19 among elderly population. [16] Studies have found an independent association of male sex with poorer outcome in COVID-19 patients. [17] However, in this study the clinical severity of the illness was not associated with the sex of the patient.

Increased total leukocyte count and differential neutrophil count was more commonly seen in patients having severe COVID-19. Yuan et al. reported similar findings in severe COVID-19 cases. [18] In this study, lymphopenia was strongly associated with severe illness. A study by Tan et al. involving 90 hospitalized patients also arrived at the same conclusion. [8] In our study, differential monocyte count and differential eosinophil count was negatively correlated with the severity of the illness. Basophil counts were unrelated to the severity of COVID-19. Also, neutrophil-lymphocyte ratio (NLR) and neutrophil-monocyte ratio (NMR) were found to be positively correlated with COVID-19 disease severity. A meta-analysis of 6 studies reported a higher NLR to be a poor prognostic marker for patients with SARS-CoV-2 infections. [19] A similar study by Yang et at also suggested that increased NLR predicts poor prognosis in COVID-19. [9] J o u r n a l P r e -p r o o f Among diabetics, mean NLR and NMR was higher when compared to their non-diabetic counterpart. In this study, an association was also found between hypertension and high NLR in COVID-19 patients. However, no association between high NMR and hypertension was seen in this study. Despite our best efforts, this study had some limitations, such as-1. Small sample size of both groups meant an increased chance of large sampling error 2. It is a single-center, non-externally validated, cross-sectional study. Bias associated with the study design could not be removed. Table2-Characteristics of differential counts in different severity groups of COVID-19. 

WHO Coronavirus Disease (COVID-19) Dashboard

Naming the coronavirus disease (COVID-19) and the virus that causes it

guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Ministry of Health and Family Welfare Government of India

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19

Covid-19: risk factors for severe disease and death

Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes/metabolism research and reviews

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Mosby's Diagnostic & Laboratory Test Reference

Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis